| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |